Prostate cancer: Incremental value of endorectal MR imaging findings for prediction of extracapsular extension

Radiology

Volumn 232, Issue 1, 2004, Pages 133-139

  Wang, Liang ^a   Mullerad, Michael ^a   Chen, Hui Ni ^a   Eberhardt, Steven C ^a   Kattan, Michael W ^a   Scardino, Peter T ^a   Hricak, Hedvig ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Magnetic resonance (MR), coils; Magnetic resonance (MR), spectroscopy; Neoplasms, staging; Prostate neoplasms; Prostate, biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 2942739010     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2321031086     Document Type: Article

References (46)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
2. Polascik TJ, Oesterling JF, Partin AW. Prostate specific antigen: a decade of discovery- what we have learned and where we are going. J Urol 1999; 162:293-306.
3. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993; 43:7-26.
4. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58:843-848.
5. Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 1997; 79:528-537.
6. Graefen M, Karakiewicz PI, Cagiannos I, et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 2002; 20:951-956.
7. Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT. Prostate cancer: detection of extracapsular extension at MR imaging by genitourinary and general body radiologists. Radiology 2004; 232:140-146.
8. Bottomley PA. Selective volume method for performing localized MR spectroscopy. U.S. patent 4 480 228, 1984.
9. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38:311-321.
10. Brown TP, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A 1982; 79:3523-3526.
11. Nelson S, Day MR, Carvajal L, et al. Methods for analysis of serial volume MRI and 1H MRS data for the assessment of response to therapy in patients with brain tumors (abstr). In: Proceedings of the Society of Magnetic Resonance in Medicine and the European Society of Magnetic Resonance in Medicine and Biology. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1995.
12. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999; 213:481-488.
13. Rubin MA, Bassily N, Sanda M, Montie J, Strawderman MS, Wojno K. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. Am J Surg Pathol 2000; 24:183-189.
14. Bismar TA, Lewis JS Jr, Vollmer RT, Humphrey PA. Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol 2003; 27:432-440.
15. Yossepowitch O, Sircar K, Scardino PT, et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol 2002; 168:2011-2015.
16. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003; 95:634-635.
17. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia, Pa: Lippincott, 1992.
18. American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia, Pa: Lippincott-Raven, 1997.
19. Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2002; 20:3206-3212.
20. Vargas SO, Jiroutek M, Welch WR, Nucci MR, D'Amico AV, Renshaw AA. Perineural invasion in prostate needle biopsy specimens: correlation with extraprostatic extension at resection. Am J Clin Pathol 1999; 111:223-228.
21. Roach M 3rd, Chen A, Song J, Diaz A, Presti J Jr, Carroll P. Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer. Semin Urol Oncol 2000; 18:108-114.
22. Paquette EL, Connelly RR, Sun L, Paquette LR, Moul JW. Predictors of extracapsular extension and positive margins in African American and white men. Urol Oncol 2003; 21:33-38.
23. Horiguchi A, Nakashima J, Horiguchi Y, et al. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. Prostate 2003; 56:23-29.
24. Ravery, V, Chastang C, Toublanc M, Boccon-Gibod L, Delmas V. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol 2000; 37:449-455.
25. Freedland SJ, Csathy GS, Dorey, F, Aronson WJ. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure of adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 2002; 167:516-520.
26. Linson PW, Lee AK, Doytchinova T, et al. Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer? Urology 2002; 59:704-708.
27. Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001; 166:402-410.
28. Bastacky SI, Walsh PC, Epstein JI. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 1993; 17:336-341.
29. Bastacky SS, Epstein JI. The sensitivity and specificity of perineural invasion on needle-biopsy of prostate-cancer in predicting capsular penetration at radical prostatectomy (abstr). Lab Invest 1991; 64:A43.
30. de la Taille A, Katz A, Bagiella E, Olsson CA, O'Toole KM, Rubin MA. Perineural invasion on prostate needle biopsy: an independent predictor of final pathologic stage. Urology 1999; 54:1039-1043.
31. Egan AJ, Bostwick DG. Prediction of extra-prostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol 1997; 21:1496-1500.
32. Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol 1998; 160:1722-1726.
33. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol 2001; 165:126-129.
34. de la Taille A, Rubin MA, Bagiella E, et al. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy? J Urol 1999; 162:103-106.
35. O'Malley KJ, Pound CP, Walsh PC, Epstein JI, Partin AW. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. Urology 2002; 59:85-90.
36. D'Amico AV. Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer. Cancer J 2001; 7:375-376.
37. Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol 2003; 169:1653-1661.
38. D'Amico AV, Whittington R, Malkowicz B, et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 2000; 164: 759-763.
39. Tempany CM. MR staging of prostate cancer: how we can improve our accuracy with decisions aids and optimal techniques. Magn Reson Imaging Clin N Am 1996; 4:519-532.
40. Tempany CM, Zhou X, Zerhouni EA, et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 1994; 192:47-54.
41. May F, Treumann T, Dettmar P, Hartung R, Breul J. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 2001; 87:66-69.
42. Cornud F, Flam T, Chauveinc L, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 2002; 224:203-210.
43. D'Amico AV, Cormack RA, Tempany CM. MRI-guided diagnosis and treatment of prostate cancer. N Engl J Med 2001; 344:776-777.
44. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 1999; 213:473-480.
45. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002; 12:2294-2302.
46. Ogura K, Maekawa S, Okubo K, et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 2001; 57:721-726.